Homology Medicines Files 8-K Amendment
Ticker: QTTB · Form: 8-K/A · Filed: Mar 22, 2024 · CIK: 1661998
| Field | Detail |
|---|---|
| Company | Homology Medicines, Inc. (QTTB) |
| Form Type | 8-K/A |
| Filed Date | Mar 22, 2024 |
| Risk Level | medium |
| Pages | 7 |
| Reading Time | 8 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: amendment, other-events
TL;DR
Homology Medicines filed an 8-K amendment on March 22nd for events on March 20th. Details TBD.
AI Summary
Homology Medicines, Inc. filed an amendment (8-K/A) on March 22, 2024, to a previous report concerning "Other Events" that occurred on March 20, 2024. The filing does not provide specific details about the nature of these events or any associated financial figures.
Why It Matters
This amendment indicates a change or addition to previously reported information, which could be significant for investors monitoring the company's activities.
Risk Assessment
Risk Level: medium — Amendments to 8-K filings often signal important updates, but the lack of specific details in this filing creates uncertainty.
Key Players & Entities
- Homology Medicines, Inc. (company) — Registrant
- March 20, 2024 (date) — Date of earliest event reported
- March 22, 2024 (date) — Filing date
FAQ
What specific "Other Events" are being amended in this 8-K/A filing?
The filing does not specify the nature of the 'Other Events' that occurred on March 20, 2024, and are being amended.
When was the original 8-K filing related to these events?
The filing does not state the date of the original 8-K filing, only that this is an amendment (8-K/A).
What is the primary purpose of an 8-K/A filing?
An 8-K/A filing is an amendment to a previously filed Form 8-K, used to correct or add information to the original report.
What is Homology Medicines, Inc.'s principal executive office address?
The principal executive offices are located at One Patriots Park, Bedford, MA 01730.
What is the SIC code for Homology Medicines, Inc.?
The Standard Industrial Classification (SIC) code is 2834, for Pharmaceutical Preparations.
Filing Stats: 2,003 words · 8 min read · ~7 pages · Grade level 20 · Accepted 2024-03-22 10:23:31
Key Financial Figures
- $0.0001 — nge on which registered Common Stock, $0.0001 par value per share FIXX The Nasdaq
Filing Documents
- d817398d8ka.htm (8-K/A) — 36KB
- 0001193125-24-074775.txt ( ) — 161KB
- fixx-20240320.xsd (EX-101.SCH) — 3KB
- fixx-20240320_lab.xml (EX-101.LAB) — 18KB
- fixx-20240320_pre.xml (EX-101.PRE) — 11KB
- d817398d8ka_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. HOMOLOGY MEDICINES, INC. Date: March 22, 2024 By: /s/ Paul Alloway, Ph.D. Paul Alloway, Ph.D. President, Chief Operating Officer and Secretary